128 related articles for article (PubMed ID: 9340976)
1. [Effect of progestins on the breast--protective or proliferative?].
Schindler AE
Zentralbl Gynakol; 1997; 119(8):359-65. PubMed ID: 9340976
[TBL] [Abstract][Full Text] [Related]
2. Oestrogens, progestins and breast proliferation.
Thijssen JH
Zentralbl Gynakol; 1997; 119 Suppl 2():43-7. PubMed ID: 9361394
[TBL] [Abstract][Full Text] [Related]
3. Progestins and breast cancer risk.
Campagnoli C; Biglia N; Giai M; Sismondi P
Zentralbl Gynakol; 1997; 119 Suppl 2():38-42. PubMed ID: 9361393
[TBL] [Abstract][Full Text] [Related]
4. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
5. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
6. [Progestins and the endometrium].
Schindler AE
Zentralbl Gynakol; 1997; 119 Suppl 2():59-63. PubMed ID: 9441543
[TBL] [Abstract][Full Text] [Related]
7. [Long-term hormone substitution and risk of breast carcinoma: current status].
Kuhl H; Runnebaum B; Schneider HP
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):M1-5. PubMed ID: 8852790
[No Abstract] [Full Text] [Related]
8. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
[TBL] [Abstract][Full Text] [Related]
9. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
[TBL] [Abstract][Full Text] [Related]
10. Progestins in the menopause in healthy women and breast cancer patients.
Pasqualini JR
Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
[TBL] [Abstract][Full Text] [Related]
11. [Hormone therapy and the risk of cancer in the climacteric].
Kuhl H; Taubert HD
Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
[No Abstract] [Full Text] [Related]
12. Effects of sex steroids on proliferation in normal mammary tissue.
Söderqvist G
Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
[TBL] [Abstract][Full Text] [Related]
13. [Estrogens or progestational agents?].
de Lignières B
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(5):579-80. PubMed ID: 6491200
[No Abstract] [Full Text] [Related]
14. [Significance of progestins in treatment of endometriosis].
Schweppe KW
Zentralbl Gynakol; 1997; 119 Suppl 2():64-9. PubMed ID: 9441544
[TBL] [Abstract][Full Text] [Related]
15. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
[TBL] [Abstract][Full Text] [Related]
16. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
17. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Holtorf K
Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
[TBL] [Abstract][Full Text] [Related]
18. [The significance of gestagens in treatment of mastopathy].
Schweppe KW
Zentralbl Gynakol; 1997; 119 Suppl 2():54-8. PubMed ID: 9441542
[TBL] [Abstract][Full Text] [Related]
19. [Postmenopausal hormone replacement therapy--is there a cause of worry?].
Skouby SO; Wilken-Jensen C; Jespersen J; Pedersen AT; Ottesen BS
Ugeskr Laeger; 2002 Aug; 164(34):3974-5. PubMed ID: 12212482
[No Abstract] [Full Text] [Related]
20. Latest on HRT & breast cancer risk.
Johns Hopkins Med Lett Health After 50; 2000 May; 12(3):1-2. PubMed ID: 10798283
[No Abstract] [Full Text] [Related]
[Next] [New Search]
